FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

(2013) K. M. Gust et al.   MOLECULAR CANCER THERAPEUTICS

Oncogenic FGFR3 gene fusions in bladder cancer

(2012) Sarah V. Williams et al.   HUMAN MOLECULAR GENETICS

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

(2012) Jeeyun Lee et al.   PLoS One

mRNA transcript quantification in archival samples using multiplexed, color-coded probes

(2011) Patricia P Reis et al.   BMC BIOTECHNOLOGY

Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma

(2011) Hikmat A Al-Ahmadie et al.   JOURNAL OF PATHOLOGY

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

(2011) Craig H Mermel et al.   GENOME BIOLOGY

FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population

(2010) Khaldon Bodoor et al.   Cancer Epidemiology

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

(2010) Wun-Jae Kim et al.   Molecular Cancer

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays

(2009) Yuker Wang et al.   BMC Medical Genomics

Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer

(2009) D. C. Tomlinson et al.   CANCER RESEARCH

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

(2009) Jing Qing et al.   JOURNAL OF CLINICAL INVESTIGATION

Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples

(2009) Laura E. MacConaill et al.   PLoS One

FGFR3 Mutations Indicate Better Survival in Invasive Upper Urinary Tract and Bladder Tumours

(2008) Johanna M.M. van Oers et al.   EUROPEAN UROLOGY

Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur

(2007) Francesca Barbisan et al.   CANCER